COMMUNIQUÉS West-GlobeNewswire

Apellis Pharmaceuticals Reports Second Quarter 2018 Business Update and Financial Results
31/07/2018
- Commenced Phase 3 Trial of APL-2 in Paroxysmal Nocturnal Hemoglobinuria (PNH); APL-2 in Geographic Atrophy (GA) Remains On Track to Advance into Phase 3 in 2H18 - - Cash Position of $253.8 Million at Quarter-End - [...]
Profound Medical to Present at the Canaccord Genuity 38th Annual Growth Conference
31/07/2018
TORONTO, July 31, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Emergent BioSolutions Initiates Phase 1 Clinical Study of Zika Virus Immune Globulin Therapeutic
31/07/2018
ZIKV-IG granted Fast Track designation by the U.S. Food and Drug Administration GAITHERSBURG, Md., July 31, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the initiation of a Phase 1 [...]
Following Azedra’s Approval, Progenics Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Update
31/07/2018
AZEDRA ® (iobenguane I 131) Approved by U.S. Food and Drug Administration (FDA); U.S. Promotion Commences Top-Line Data from Phase 3 Trial for PSMA-Targeted SPECT/CT Imaging Agent 1404 Expected in Q3’18 Top-Line Data [...]
Corvus Pharmaceuticals to Present at 2018 Wedbush PacGrow Healthcare Conference
31/07/2018
BURLINGAME, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Capital Senior Living Corporation Reports Second Quarter 2018 Results
31/07/2018
DALLAS, July 31, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE:CSU), one of the nation’s largest operators of senior housing communities, today announced operating and financial [...]
Precision Optics Corporation, Inc. Announces Fourth Quarter 2018 Preliminary Revenue of $1.4 - $1.5 Million
31/07/2018
GARDNER, Mass., July 31, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”), a leading developer and manufacturer of advanced micro-optical components used in next generation [...]
Pernix Therapeutics to Report Second Quarter 2018 Financial Results on Thursday, August 9
31/07/2018
MORRISTOWN, N.J., July 31, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that the Company will report financial results for the second [...]
Amedisys Reports Second Quarter 2018 Financial Results and Updates 2018 Guidance
31/07/2018
BATON ROUGE, La., July 31, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month period ended June 30, 2018. Three Month Periods Ended June 30, 2018 and [...]
Amedisys Signs Definitive Agreement to Acquire Bring Care Home
31/07/2018
BATON ROUGE, La., July 31, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of the nation’s leading home healthcare, hospice and personal care companies, announced today that its subsidiary, Associated Home [...]
Geron Corporation Reports Second Quarter 2018 Financial Results and Recent Company Events
31/07/2018
Conference Call Scheduled for July 31 at 4:30 p.m. ET MENLO PARK, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the three and six months ended June 30, [...]
AC Immune Announces Successful Closing of Second Subscription Rights Offering
31/07/2018
Gross Proceeds of All Three Offerings of 10 Million Common Shares in Total Aggregate to USD 117.5 Million Lausanne, Switzerland, July 31, 2018 - AC Immune, SA (NASDAQ: ACIU), a Swiss-based, clinical-stage [...]
Cara Therapeutics to Announce Second Quarter 2018 Financial Results on August 7, 2018
31/07/2018
STAMFORD, Conn., July 31, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]
Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)
31/07/2018
Oasmia Pharmaceutical AB (publ) (”Oasmia”) on the 29 November 2017 issued a convertible loan with a total nominal amount of MSEK 28. In total MSEK 9 of the convertible loan have during July, at the request of [...]
Cellectar Biosciences Announces Closing of $16.56 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
31/07/2018
MADISON, Wis., July 31, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of [...]
Prothena to Report Second Quarter 2018 Financial Results on August 7
31/07/2018
DUBLIN, Ireland, July 31, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical-stage neuroscience company, will announce financial results for the second quarter and first six months of 2018 on [...]
Myriad Announces Closing of Counsyl Acquisition
31/07/2018
Transformational Acquisition Enhances Myriad’s Leadership Position in Women’s Health SALT LAKE CITY, July 31, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, [...]
OmniSeq, Inc. to Participate in the NCI-MATCH Clinical Trial
31/07/2018
Having Met Rigorous Qualifications, OmniSeq Becomes One of Several Commercial and Academic Laboratories Designated by the National Cancer Institute to Cast a Wider Net for Patients to Enter the NCI-MATCH Trial BUFFALO, [...]
Zafgen to Host Conference Call to Discuss Second Quarter 2018 Financial Results
31/07/2018
BOSTON, July 31, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]

Pages